Deepak L Bhatt Selected Research

omega-Chloroacetophenone (Mace)

10/2022	Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial.
10/2022	Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES.
8/2022	Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
2/2022	Comparing benefits from sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in randomized clinical trials: a network meta-analysis.
2/2022	Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI.
1/2022	Association of Baseline HbA1c With Cardiovascular and Renal Outcomes: Analyses From DECLARE-TIMI 58.
1/2022	Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trial.
1/2022	Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
1/2022	Alirocumab after acute coronary syndrome in patients with a history of heart failure.
1/2022	Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deepak L Bhatt Research Topics

Disease

299	Myocardial Infarction 12/2022 - 01/2002
252	Hemorrhage 12/2022 - 06/2002
181	Stroke (Strokes) 12/2022 - 04/2002
152	Thrombosis (Thrombus) 12/2022 - 02/2002
151	Acute Coronary Syndrome 10/2022 - 04/2002
134	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 01/2002
122	Heart Failure 11/2022 - 07/2007
94	Coronary Artery Disease (Coronary Atherosclerosis) 12/2022 - 04/2002
93	Type 2 Diabetes Mellitus (MODY) 12/2022 - 05/2010
91	Ischemic Stroke 10/2022 - 02/2004
86	Atrial Fibrillation 07/2022 - 01/2008
65	ST Elevation Myocardial Infarction 03/2022 - 05/2003
57	Diabetes Mellitus 12/2022 - 09/2002
50	Hypertension (High Blood Pressure) 01/2022 - 01/2006
46	Peripheral Arterial Disease 12/2022 - 08/2004
43	Ischemia 03/2022 - 02/2004
34	Unstable Angina 10/2022 - 04/2003
31	Vascular Diseases (Vascular Disease) 10/2022 - 09/2005
28	Coronary Disease (Coronary Heart Disease) 10/2022 - 03/2003
27	Chronic Renal Insufficiency 11/2022 - 05/2002
25	Atherosclerosis 08/2022 - 07/2003
23	Obesity 01/2022 - 07/2006
21	Inflammation (Inflammations) 07/2022 - 02/2002
17	Neoplasms (Cancer) 05/2022 - 12/2009
16	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 01/2012
15	Weight Loss (Weight Reduction) 01/2022 - 07/2006
15	Dyslipidemias (Dyslipidemia) 01/2022 - 07/2006
14	COVID-19 11/2022 - 09/2020
13	Cardiogenic Shock 01/2022 - 01/2002
13	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2017
12	Non-ST Elevated Myocardial Infarction 02/2022 - 07/2009
12	Pathologic Constriction (Stenosis) 10/2021 - 03/2004
10	Infections 10/2021 - 10/2018
9	Body Weight (Weight, Body) 01/2022 - 04/2008
9	Transient Ischemic Attack 01/2021 - 12/2006
9	Cerebral Hemorrhage 01/2021 - 11/2011
9	Hypercholesterolemia 12/2020 - 10/2004
9	Renal Insufficiency (Renal Failure) 01/2018 - 04/2005

Drug/Important Bio-Agent (IBA)

163	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2022 - 06/2002
128	Clopidogrel (Plavix)FDA Link 01/2022 - 01/2002
76	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 02/2002
73	omega-Chloroacetophenone (Mace)IBA 10/2022 - 01/2002
49	TicagrelorIBA 12/2022 - 03/2013
48	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2022 - 06/2010
48	AnticoagulantsIBA 01/2022 - 01/2005
43	cangrelorIBA 03/2022 - 12/2009
34	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 05/2007
33	RivaroxabanIBA 12/2022 - 01/2012
33	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 01/2006
31	Warfarin (Coumadin)FDA LinkGeneric 12/2021 - 10/2011
28	LipidsIBA 01/2022 - 02/2002
26	alirocumabIBA 10/2022 - 11/2014
26	LDL CholesterolIBA 10/2022 - 09/2009
25	Pharmaceutical PreparationsIBA 02/2022 - 07/2006
25	dapagliflozinIBA 01/2022 - 01/2018
24	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2004
24	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 05/2002
23	Dabigatran FDA Link 01/2022 - 07/2015
22	eicosapentaenoic acid ethyl esterIBA 01/2022 - 01/2019
22	saxagliptin FDA Link 11/2021 - 11/2011
21	oxidized low density lipoproteinIBA 10/2022 - 09/2009
21	Triglycerides (Triacylglycerol)IBA 10/2021 - 08/2010
19	CholesterolIBA 08/2022 - 12/2006
19	Sodium-Glucose Transport ProteinsIBA 01/2022 - 11/2018
18	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2022 - 01/2018
18	CreatinineIBA 01/2022 - 10/2003
18	MetalsIBA 01/2021 - 03/2005
15	Antihypertensive Agents (Antihypertensives)IBA 12/2021 - 06/2009
15	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 10/2008
14	Prasugrel Hydrochloride FDA Link 03/2022 - 05/2008
14	Vitamin K FDA Link 01/2022 - 12/2016
14	Glycoproteins (Glycoprotein)IBA 01/2019 - 06/2002
13	TroponinIBA 02/2022 - 08/2015
12	SodiumIBA 11/2022 - 01/2018
12	C-Reactive ProteinIBA 08/2022 - 07/2003
12	Heparin (Liquaemin)FDA LinkGeneric 11/2020 - 01/2003
11	salicylhydroxamic acid (SHAM)IBA 02/2022 - 04/2014
11	Angiotensin Receptor AntagonistsIBA 01/2020 - 09/2011
10	empagliflozinIBA 11/2022 - 11/2018
10	Proprotein Convertase 9IBA 08/2022 - 01/2018
10	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 07/2022 - 01/2018
10	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 07/2006

Therapy/Procedure

348	Therapeutics 12/2022 - 06/2002
188	Percutaneous Coronary Intervention 12/2022 - 01/2002
130	Stents 12/2022 - 01/2002
47	Secondary Prevention 01/2022 - 05/2003
38	Drug-Eluting Stents 11/2021 - 06/2006
32	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 06/2022 - 04/2006
27	Length of Stay 12/2021 - 11/2009
19	Transcatheter Aortic Valve Replacement 01/2021 - 06/2012
17	Denervation 12/2021 - 09/2012
17	Bariatric Surgery 11/2020 - 05/2010
16	Surgical Amputation (Amputations) 01/2022 - 07/2009
16	Catheters 01/2022 - 09/2004
13	Patient Readmission 01/2021 - 02/2004
12	Thrombolytic Therapy 02/2022 - 08/2014
11	Blood Transfusion (Blood Transfusions) 02/2022 - 01/2003
11	Glycemic Control 01/2021 - 08/2004
10	Thrombectomy 01/2018 - 12/2008
9	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 11/2019 - 09/2011